Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

Johnson, JL, Stoica, L, Liu, Y, Zhu, PJ, Bhattacharya, A, Buffington, SA, Huq, R, Eissa, NT, Larsson, O, Porse, BT, Domingo, D, Nawaz, U, Carroll, R, Jolly, L, Scerri, TS, Kim, H-G, Brignell, A, Coleman, MJ, Braden, R, Kini, U, Jackson, V, Baxter, A, Bahlo, M, Scheffer, IE, Amor, DJ, Hildebrand, MS, Bonnen, PE, Beeton, C, Gecz, J, Morgan, AT & Costa-Mattioli, M 2019, 'Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response' Neuron, bind 104, nr. 4, s. 665-679.e8. https://doi.org/10.1016/j.neuron.2019.08.027

APA

Johnson, J. L., Stoica, L., Liu, Y., Zhu, P. J., Bhattacharya, A., Buffington, S. A., ... Costa-Mattioli, M. (2019). Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response. Neuron, 104(4), 665-679.e8. https://doi.org/10.1016/j.neuron.2019.08.027

CBE

Johnson JL, Stoica L, Liu Y, Zhu PJ, Bhattacharya A, Buffington SA, Huq R, Eissa NT, Larsson O, Porse BT, Domingo D, Nawaz U, Carroll R, Jolly L, Scerri TS, Kim H-G, Brignell A, Coleman MJ, Braden R, Kini U, Jackson V, Baxter A, Bahlo M, Scheffer IE, Amor DJ, Hildebrand MS, Bonnen PE, Beeton C, Gecz J, Morgan AT, Costa-Mattioli M. 2019. Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response. Neuron. 104(4):665-679.e8. https://doi.org/10.1016/j.neuron.2019.08.027

MLA

Vancouver

Author

Johnson, Jennifer L ; Stoica, Loredana ; Liu, Yuwei ; Zhu, Ping Jun ; Bhattacharya, Abhisek ; Buffington, Shelly A ; Huq, Redwan ; Eissa, N Tony ; Larsson, Ola ; Porse, Bo T ; Domingo, Deepti ; Nawaz, Urwah ; Carroll, Renee ; Jolly, Lachlan ; Scerri, Tom S ; Kim, Hyung-Goo ; Brignell, Amanda ; Coleman, Matthew J ; Braden, Ruth ; Kini, Usha ; Jackson, Victoria ; Baxter, Anne ; Bahlo, Melanie ; Scheffer, Ingrid E ; Amor, David J ; Hildebrand, Michael S ; Bonnen, Penelope E ; Beeton, Christine ; Gecz, Jozef ; Morgan, Angela T ; Costa-Mattioli, Mauro. / Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response. I: Neuron. 2019 ; Bind 104, Nr. 4. s. 665-679.e8.

Bibtex

@article{5eb4397c542b4339ae7619f589bab199,
title = "Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response",
abstract = "In humans, disruption of nonsense-mediated decay (NMD) has been associated with neurodevelopmental disorders (NDDs) such as autism spectrum disorder and intellectual disability. However, the mechanism by which deficient NMD leads to neurodevelopmental dysfunction remains unknown, preventing development of targeted therapies. Here we identified novel protein-coding UPF2 (UP-Frameshift 2) variants in humans with NDD, including speech and language deficits. In parallel, we found that mice lacking Upf2 in the forebrain (Upf2 fb-KO mice) show impaired NMD, memory deficits, abnormal long-term potentiation (LTP), and social and communication deficits. Surprisingly, Upf2 fb-KO mice exhibit elevated expression of immune genes and brain inflammation. More importantly, treatment with two FDA-approved anti-inflammatory drugs reduced brain inflammation, restored LTP and long-term memory, and reversed social and communication deficits. Collectively, our findings indicate that impaired UPF2-dependent NMD leads to neurodevelopmental dysfunction and suggest that anti-inflammatory agents may prove effective for treatment of disorders with impaired NMD.",
keywords = "autism, immune response, memory, mRNA quality control, neurodevelopmental disorders, speech disorder",
author = "Johnson, {Jennifer L} and Loredana Stoica and Yuwei Liu and Zhu, {Ping Jun} and Abhisek Bhattacharya and Buffington, {Shelly A} and Redwan Huq and Eissa, {N Tony} and Ola Larsson and Porse, {Bo T} and Deepti Domingo and Urwah Nawaz and Renee Carroll and Lachlan Jolly and Scerri, {Tom S} and Hyung-Goo Kim and Amanda Brignell and Coleman, {Matthew J} and Ruth Braden and Usha Kini and Victoria Jackson and Anne Baxter and Melanie Bahlo and Scheffer, {Ingrid E} and Amor, {David J} and Hildebrand, {Michael S} and Bonnen, {Penelope E} and Christine Beeton and Jozef Gecz and Morgan, {Angela T} and Mauro Costa-Mattioli",
note = "Copyright {\circledC} 2019. Published by Elsevier Inc.",
year = "2019",
month = "11",
day = "20",
doi = "10.1016/j.neuron.2019.08.027",
language = "English",
volume = "104",
pages = "665--679.e8",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "4",

}

RIS

TY - JOUR

T1 - Inhibition of Upf2-Dependent Nonsense-Mediated Decay Leads to Behavioral and Neurophysiological Abnormalities by Activating the Immune Response

AU - Johnson, Jennifer L

AU - Stoica, Loredana

AU - Liu, Yuwei

AU - Zhu, Ping Jun

AU - Bhattacharya, Abhisek

AU - Buffington, Shelly A

AU - Huq, Redwan

AU - Eissa, N Tony

AU - Larsson, Ola

AU - Porse, Bo T

AU - Domingo, Deepti

AU - Nawaz, Urwah

AU - Carroll, Renee

AU - Jolly, Lachlan

AU - Scerri, Tom S

AU - Kim, Hyung-Goo

AU - Brignell, Amanda

AU - Coleman, Matthew J

AU - Braden, Ruth

AU - Kini, Usha

AU - Jackson, Victoria

AU - Baxter, Anne

AU - Bahlo, Melanie

AU - Scheffer, Ingrid E

AU - Amor, David J

AU - Hildebrand, Michael S

AU - Bonnen, Penelope E

AU - Beeton, Christine

AU - Gecz, Jozef

AU - Morgan, Angela T

AU - Costa-Mattioli, Mauro

N1 - Copyright © 2019. Published by Elsevier Inc.

PY - 2019/11/20

Y1 - 2019/11/20

N2 - In humans, disruption of nonsense-mediated decay (NMD) has been associated with neurodevelopmental disorders (NDDs) such as autism spectrum disorder and intellectual disability. However, the mechanism by which deficient NMD leads to neurodevelopmental dysfunction remains unknown, preventing development of targeted therapies. Here we identified novel protein-coding UPF2 (UP-Frameshift 2) variants in humans with NDD, including speech and language deficits. In parallel, we found that mice lacking Upf2 in the forebrain (Upf2 fb-KO mice) show impaired NMD, memory deficits, abnormal long-term potentiation (LTP), and social and communication deficits. Surprisingly, Upf2 fb-KO mice exhibit elevated expression of immune genes and brain inflammation. More importantly, treatment with two FDA-approved anti-inflammatory drugs reduced brain inflammation, restored LTP and long-term memory, and reversed social and communication deficits. Collectively, our findings indicate that impaired UPF2-dependent NMD leads to neurodevelopmental dysfunction and suggest that anti-inflammatory agents may prove effective for treatment of disorders with impaired NMD.

AB - In humans, disruption of nonsense-mediated decay (NMD) has been associated with neurodevelopmental disorders (NDDs) such as autism spectrum disorder and intellectual disability. However, the mechanism by which deficient NMD leads to neurodevelopmental dysfunction remains unknown, preventing development of targeted therapies. Here we identified novel protein-coding UPF2 (UP-Frameshift 2) variants in humans with NDD, including speech and language deficits. In parallel, we found that mice lacking Upf2 in the forebrain (Upf2 fb-KO mice) show impaired NMD, memory deficits, abnormal long-term potentiation (LTP), and social and communication deficits. Surprisingly, Upf2 fb-KO mice exhibit elevated expression of immune genes and brain inflammation. More importantly, treatment with two FDA-approved anti-inflammatory drugs reduced brain inflammation, restored LTP and long-term memory, and reversed social and communication deficits. Collectively, our findings indicate that impaired UPF2-dependent NMD leads to neurodevelopmental dysfunction and suggest that anti-inflammatory agents may prove effective for treatment of disorders with impaired NMD.

KW - autism

KW - immune response

KW - memory

KW - mRNA quality control

KW - neurodevelopmental disorders

KW - speech disorder

U2 - 10.1016/j.neuron.2019.08.027

DO - 10.1016/j.neuron.2019.08.027

M3 - Journal article

VL - 104

SP - 665-679.e8

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 4

ER -

ID: 58182026